INmune Bio Inc. Common stock
$2.03
▲ +0.03
(+1.50%)
Volume: 193,634
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
33
- 21d momentum -17.0%
- RSI 43
🎯
Pullback
62
- Near lower Bollinger band
- -9.8% vs 20MA
💎
Value
58
- -22% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)43.3
MACD-0.049
MA trendMixed
ATR7.44%
21d mom.-17.0%
63d mom.+43.0%
vs 20MA-9.8%
RVOL(20)0.54×
52w low · 1
52w high · 3
-21.9% from 52-week high
20d support 2
· resistance 3
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$56M
PER—
PBR2.73
PSR—
EPS$-0.66
ROE-90.4%
ROA-68.6%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-1.86
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -12.88% | -16.97% | +42.96% | +69.17% | +4.10% | +31.82% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -16.80%, daily vol 4.51%. INmune Bio Inc. Common stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.